Tc-DTPA is a well-known agent for evaluation of renal function. It is cleared rapidly and efficiently from the circulation by glomerular filtration. This might explain, for liposomes, the unusual, rapid accumulation of activity in the tumours. In our opinion, the authors should have performed, and shown -at least in some patients -a control 99m Tc-DTPA scan, to rule out that the liposome scan represents free 99m Tc-DTPA instead of radiolabelled Caelyx.
A better approach to label Caelyx would be the labelling with indium-111-oxine ( 111 In-oxine). This easy method will yieldradiolabelled liposomes with good radiochemical yield (480%) and good in vivo stability (Laverman et al, 2001 ). An additional advantage is the longer physical half-life of 111 In, which enables the acquisition of delayed images and thus better visualization of the tumours (Harrington et al, 2001) .
In summary, scintigraphic techniques are very helpful in investigating the in vivo distribution of (new) pharmaceuticals, but should only be performed using well-established labelling techniques and quality control methods. The results presented by Koukourakis et al (1999 Koukourakis et al ( , 2000a should therefore be interpreted with caution. 
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Sir
In these previous studies we provided a simple method to label Caelyx by incubation of 5 mg of the ready-to-use solution with 20 mCi of 99m Tc-DTPA. Instant thin layer chromatography (ITLC) suggested an 80% labelling (Koukourakis et al, 1999) , which is also a result found by Dr Laverman and colleagues. As additional more sophisticated analysis, performed by the later research group, failed to confirm this finding, it was suggested that the tumour and body imaging obtained in our studies is rather a result of 99m Tc-DTPA and not of labelled liposomes.
99m Tc-DTPA is currently used in the evaluation of renal function, and as well noted by Dr Laverman, this is rapidly cleared from the kidneys. Two hours following injection, the imaging quality of kidneys is really poor.
99m Tc-DTPA can give good images of gliomas, probably as a result of the high tumour vascularization or even of the disrupted blood -brain barrier, which allows a net contrast between normal and abnormal brain. However, imaging of other tumours with We believe that the best answer to whether our simple labelling technique labels Caelyx indeed, comes from the clinical practice. The patterns and quality of imaging using 99m Tc-DTPA-Caelyx has been assessed in more than 30 non-small cell lung cancer patients comparatively with 99m Tc-sestamibi (Koukourakis et al, 1997) , while in five of them imaging with simple 99m Tc-DTPA was also performed at 2 h post-injection. The patterns of normal tissue imaging using the three radio-pharmaceuticals was entirely different. The quality of tumour images obtained with sestamibi and labelled-Caelyx was very good, while in some cases liposomal imaging was even better. Tumour imaging with 99m Tc-DTPA was of unacceptably poor quality, and rather absent in 3 out of 5 cases. Similar comparison of the three imaging procedures in patients with head and neck cancer showed an excellent imaging using labelled-Caelyx and 99m Tc-sestamibi, while using 99m Tc-DTPA the imaging was questionable especially at 2 h post-injection ( Figure  1 ). The superiority of liposomal imaging over sestamibi was confirmed in more than 10 glioma patients. Indeed, lesions of some mm in dimensions were perfectly scanned using 99m Tc-DTPA-Caelyx (Koukourakis et al, 2000a) , which is rarely seen with sestamibi.
We, therefore, have to cope with a discrepancy between the clinical imaging and the 1% labelling suggested by Dr Laverman. 99m Tc-DTPA is a hydrophilic compound and, as well stressed by Dr Laverman and colleagues, it is difficult to explain how a hydrophilic radiotracer can pass through the lipid layer and become entrapped in the liposomes. There are two possibilities: (a) our labelling procedure is not efficient and 99m Tc-DTPA scanning is the cheapest, still the best, imaging procedure for tumours (which is not true according to ours and the general experience); (b) 99m Tc-DTPA labels liposomes without passing through the lipid layer. Caelyx is a pegylated liposome with a water soluble polyethylen-glycol coat. Tc-DTPA dissociation from the PEG-coat, which explains the poor labelling efficiency found.
Simple labelling procedures of liposomal drugs will become of great value within the following years, when multiple liposomal agents will be available. The technique described by Laverman et al (2001) is as simple as ours, while the Indium-oxine labelling allows a better monitoring of the liposome kinetics for at least 3 days after administration. We will certainly incorporate this in current and future projects. 
